Literature DB >> 21377864

Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer.

Liam Van Benthuysen1, Lee Hales, Matthew B Podgorsak.   

Abstract

Several studies have demonstrated that volumetric modulated arc therapy (VMAT) has the ability to reduce monitor units and treatment time when compared with intensity-modulated radiation therapy (IMRT). This study aims to demonstrate that VMAT is able to provide adequate organs at risk (OAR) sparing and planning target volume (PTV) coverage for adenocarcinoma of the distal esophagus while reducing monitor units and treatment time. Fourteen patients having been treated previously for esophageal cancer were planned using both VMAT and IMRT techniques. Dosimetric quality was evaluated based on doses to several OARs, as well as coverage of the PTV. Treatment times were assessed by recording the number of monitor units required for dose delivery. Body V(5) was also recorded to evaluate the increased volume of healthy tissue irradiated to low doses. Dosimetric differences in OAR sparing between VMAT and IMRT were comparable. PTV coverage was similar for the 2 techniques but it was found that IMRT was capable of delivering a slightly more homogenous dose distribution. Of the 14 patients, 12 were treated with a single arc and 2 were treated with a double arc. Single-arc plans reduced monitor units by 42% when compared with the IMRT plans. Double-arc plans reduced monitor units by 67% when compared with IMRT. The V(5) for the body was found to be 18% greater for VMAT than for IMRT. VMAT has the capability to decrease treatment times over IMRT while still providing similar OAR sparing and PTV coverage. Although there will be a smaller risk of patient movement during VMAT treatments, this advantage comes at the cost of delivering small doses to a greater volume of the patient. Copyright Â
© 2011 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21377864     DOI: 10.1016/j.meddos.2010.09.009

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  21 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.

Authors:  Li Yin; Hao Wu; Jian Gong; Jian-Hao Geng; Fan Jiang; An-Hui Shi; Rong Yu; Yong-Heng Li; Shu-Kui Han; Bo Xu; Guang-Ying Zhu
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

3.  Is dose escalation achievable for esophageal carcinoma?

Authors:  Laure Vieillevigne; Marie Vidal; Françoise Izar; Michel Rives
Journal:  Rep Pract Oncol Radiother       Date:  2015-01-05

4.  Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients.

Authors:  Stefania Martini; Francesca Arcadipane; Paolo Strignano; Rosella Spadi; Viviana Contu; Christian Fiandra; Riccardo Ragona; Giorgia Catalano; Maria Antonietta Satolli; Michele Camandona; Renato Romagnoli; Umberto Ricardi; Pierfrancesco Franco
Journal:  Med Oncol       Date:  2018-10-04       Impact factor: 3.064

5.  Comparison of nodal irradiation dose using radiotherapy for patients with thoracic esophageal cancer.

Authors:  Ni Zhang; Min Gu; Jiahao Wang; Shixiu Wu
Journal:  Oncol Lett       Date:  2019-12-03       Impact factor: 2.967

6.  Volumetric modulated arc therapy vs. c-IMRT for the treatment of upper thoracic esophageal cancer.

Authors:  Wu-Zhe Zhang; Tian-Tian Zhai; Jia-Yang Lu; Jian-Zhou Chen; Zhi-Jian Chen; De-Rui Li; Chuang-Zhen Chen
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

7.  Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer.

Authors:  Tao Zhang; Zhi-Wen Liang; Jun Han; Jian-Ping Bi; Zhi-Yong Yang; Hong Ma
Journal:  Radiat Oncol       Date:  2015-05-19       Impact factor: 3.481

8.  Comparison of patient-specific intensity modulated radiation therapy quality assurance for the prostate across multiple institutions.

Authors:  Kazuki Kubo; Hajime Monzen; Kohei Shimomura; Kenji Matsumoto; Tomoharu Sato; Mikoto Tamura; Kiyoshi Nakamatsu; Kentaro Ishii; Ryu Kawamorita
Journal:  Rep Pract Oncol Radiother       Date:  2019-10-17

Review 9.  Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.

Authors:  Daniel Buergy; Frank Lohr; Tobias Baack; Kerstin Siebenlist; Stefan Haneder; Henrik Michaely; Frederik Wenz; Judit Boda-Heggemann
Journal:  Radiat Oncol       Date:  2012-11-16       Impact factor: 3.481

10.  A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers.

Authors:  Antonella Fogliata; Giorgia Nicolini; Alessandro Clivio; Eugenio Vanetti; Sarbani Laksar; Angelo Tozzi; Marta Scorsetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2015-10-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.